Outlook Therapeutics (OTLK) Share-based Compensation Growth (1y) (2016 - 2026)
Outlook Therapeutics (OTLK) Share-based Compensation Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-69.95% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Outlook Therapeutics |
51.56 Mn |
43.81 Mn |
-21,888.00 |
-55.54% |
| Date | Value |
|---|
| Mar 31, 2026 |
-55.54% |
| Dec 31, 2025 |
-76.01% |
| Sep 30, 2025 |
26.81% |
| Jun 30, 2025 |
19.66% |
| Mar 31, 2025 |
30.00% |
| Dec 31, 2024 |
188.57% |
| Sep 30, 2024 |
1.17% |
| Jun 30, 2024 |
1.05% |
| Mar 31, 2024 |
-5.27% |
| Dec 31, 2023 |
-8.60% |
| Sep 30, 2023 |
0.97% |
| Jun 30, 2023 |
1.02% |
| Mar 31, 2023 |
-63.23% |
| Dec 31, 2022 |
15.64% |
| Sep 30, 2022 |
-2.02% |
| Jun 30, 2022 |
14.14% |
| Mar 31, 2022 |
233.07% |
| Dec 31, 2021 |
4.28% |
| Sep 30, 2021 |
78.99% |
| Jun 30, 2021 |
-11.80% |
